Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
Tuberculosis
Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
Read More
Step UP For TB: Report shows new tests and drugs for world’s deadliest infectious disease remain out of reach
Read More
Hamari Awaaz: Addressing stigma in people living with multidrug-resistant tuberculosis in India
Read More
endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India
Read More
Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen
Read More
Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price
Read More
Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”
Read More
World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen
Read More
COVID-19: Avoiding a ‘second tragedy’ for those with TB
Read More
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug
Read More